Dr. Vinod Raina is one of India\'s foremost Medical Oncologists with more than 30 years\' experience in the field of Medical Oncology. Till recently he was Professor and Head of Medical Oncology at AIIMS. He has performed approximately 250 bone marrow transplants personally and under his headship, AIIMS performed the largest number of transplants in India for various cancers in the last 10 years with special interest in Breast, Lung Cancer, Lymphomas, Acute and Chronic Leukemia\'s, Bone Marrow, Stem Cell transplants and GI cancers.
Education & Training
Professor of Medical Oncology at AIIMS 2001-2013
Head Medical Oncology Department at AIIMS April 2007-2013
Head Cancer Center, Royal Hospital, Muscat, Oman: 2 years and 4 months (2001-2004)
Conducted DM course in Medical Oncology for the last 15 years, have trained about 60 DM students, these students are holding consultant positions at important places in India and abroad
Transplants; Performed first high dose chemotherapy and peripheral blood stem cell transplant in India in 1994, till now have personally performed approximately 250 transplants including approximately
Hon Research Fellow of Oxford University for 5 years (2005-1010)
Headed Delhi Cancer Registry at AIIMS for 5 years. (2005-2010)
Headed Record Section of IRCH AIIMS for 3 years.
Associate Editor of Annals of Oncology 2008-2011
Acute and Chronic Leukemias
Bone marrow and Stem Cell transplants and GI cancers
Research and Publications
Principal investigator of approximately 50 projects in AIIMS, the largest number.
Received research funding from Oxford University, University of London, National Cancer Institute USA, DBT, and ICMR and various drug trial sponsors.
Disclaimer: Lyfboat does not provide professional medical opinion on the treatment or diagnosis of a particular ailment. All the offered services and information presented on www.lyfboat.com are only for the purpose of public knowledge and cannot substitute the professional consultation of the physician. Lyfboat strongly advice against copying or cloning of its web content and follows the legal protocols for protection of its intellectual property.